455 related articles for article (PubMed ID: 32102689)
1. Mineral bone disorder and osteoporosis in hemodialysis patients.
Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
[TBL] [Abstract][Full Text] [Related]
2. New Markers of Bone Fragility in Hemodialysis Patients: A Monocentric Study.
Slouma M; Aissaoui T; Abbes M; Bahlous A; Laadhar L; Smaoui W; Gharsallah I; Ben Moussa F; Elleuch M; Sahli H; Cheour E
J Clin Densitom; 2021; 24(1):22-27. PubMed ID: 33288423
[TBL] [Abstract][Full Text] [Related]
3. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women.
Hu W; He J; Fu W; Wang C; Yue H; Gu J; Zhang H; Zhang Z
J Clin Densitom; 2019; 22(2):179-184. PubMed ID: 30228048
[TBL] [Abstract][Full Text] [Related]
5. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
[TBL] [Abstract][Full Text] [Related]
7. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
8. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
[TBL] [Abstract][Full Text] [Related]
9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis.
Ahmadi F; Salari S; Maziar S; Esfahanian F; Khazaeipour Z; Ranjbarnovin N
Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
[TBL] [Abstract][Full Text] [Related]
12. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
Li M; Lv F; Zhang Z; Deng W; Li Y; Deng Z; Jiang Y; Wang O; Xing X; Xu L; Xia W
Osteoporos Int; 2016 May; 27(5):1907-16. PubMed ID: 26733373
[TBL] [Abstract][Full Text] [Related]
14. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.
Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and bone turnover in patients with psoriatic arthritis.
Borman P; Babaoğlu S; Gur G; Bingol S; Bodur H
Clin Rheumatol; 2008 Apr; 27(4):443-7. PubMed ID: 17876648
[TBL] [Abstract][Full Text] [Related]
18. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB
Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940
[TBL] [Abstract][Full Text] [Related]
19. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
20. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
